Apyx Medical Corp
APYXCIK 0000719135 · Surgical & Medical Instruments & Apparatus · Nasdaq
- BOVIE MEDICAL CORP (until 2019-01-02)
- BOVIE MEDICAL Corp (until 2019-01-02)
- AN CON GENETICS INC (until 1999-01-13)
Revenue (TTM)
$46.17M
+9.9% YoY
Q1 May 2026
Net Income (TTM)
−$12.02M
+52.2% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.57
+19.4% YoY
Q1 May 2026
Gross Margin
62.7%
Q1 May 2026
Operating Margin
-16.0%
Q1 May 2026
Net Margin
-26.0%
Q1 May 2026
Free Cash Flow (TTM)
−$9.76M
Q1 May 2026
Cash
$31.14M
Q1 May 2026
Total Debt
$43.98M
Q1 May 2026
Shares Outstanding
41.87M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
Balance Sheet
Cash vs Debt
Latest news
All news →-
High Neutral
Apyx Medical (APYX) Names Stavros Vizirgianakis Executive Chairman
Apyx Medical appointed board member Stavros Vizirgianakis as Executive Chairman and granted him 450,000 restricted stock units with no cash pay.